Elixinol Wellness Ltd (EXL) - Net Assets

Latest as of June 2025: AU$6.96 Million AUD ≈ $4.93 Million USD

Based on the latest financial reports, Elixinol Wellness Ltd (EXL) has net assets worth AU$6.96 Million AUD (≈ $4.93 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$16.58 Million ≈ $11.73 Million USD) and total liabilities (AU$9.61 Million ≈ $6.80 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check EXL financial resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$6.96 Million
% of Total Assets	42.01%
Annual Growth Rate	-10.58%
5-Year Change	-71.88%
10-Year Change	-97.45%
Growth Volatility	48.93

Elixinol Wellness Ltd - Net Assets Trend (2002–2024)

This chart illustrates how Elixinol Wellness Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Elixinol Wellness Ltd assets under control for the complete picture of this company's asset base.

Annual Net Assets for Elixinol Wellness Ltd (2002–2024)

The table below shows the annual net assets of Elixinol Wellness Ltd from 2002 to 2024. For live valuation and market cap data, see EXL company net worth.

Year	Net Assets	Change
2024-12-31	AU$10.03 Million ≈ $7.09 Million	+55.15%
2023-12-31	AU$6.46 Million ≈ $4.57 Million	-29.44%
2022-12-31	AU$9.16 Million ≈ $6.48 Million	-51.99%
2021-12-31	AU$19.08 Million ≈ $13.50 Million	-46.49%
2020-12-31	AU$35.65 Million ≈ $25.23 Million	-67.99%
2019-12-31	AU$111.38 Million ≈ $78.81 Million	-22.51%
2018-12-31	AU$143.74 Million ≈ $101.70 Million	+45.06%
2017-12-31	AU$99.09 Million ≈ $70.11 Million	-0.33%
2016-12-31	AU$99.42 Million ≈ $70.34 Million	-74.69%
2005-12-31	AU$392.73 Million ≈ $277.88 Million	+50.56%
2004-12-31	AU$260.84 Million ≈ $184.56 Million	+48.89%
2003-12-31	AU$175.18 Million ≈ $123.95 Million	+49.41%
2002-12-31	AU$117.25 Million ≈ $82.96 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Elixinol Wellness Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 955.2% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	AU$228.29 Million	2276.99%
Other Comprehensive Income	AU$9.61 Million	95.85%
Total Equity	AU$10.03 Million	100.00%

Elixinol Wellness Ltd Competitors by Market Cap

The table below lists competitors of Elixinol Wellness Ltd ranked by their market capitalization.

Company	Market Cap
Sino Hua-An International Bhd KLSE:2739	$2.05 Million
Liontrust Asset Management LSE:LIO	$2.05 Million
Aker Carbon Capture ASA OL:ACC	$2.05 Million
Fastator AB ST:FASTAT	$2.06 Million
Ferrexpo PLC LSE:FXPO	$2.05 Million
Playfair Mining Ltd. V:PLY	$2.04 Million
Optima Health plc LSE:OPT	$2.04 Million
BLAZE Minerals Ltd AU:BLZ	$2.03 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Elixinol Wellness Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 6,462,000 to 10,026,000, a change of 3,564,000 (55.2%).
Net loss of 1,722,000 reduced equity.
Share repurchases of 564,000 reduced equity.
New share issuances of 4,659,000 increased equity.
Other comprehensive income decreased equity by 432,000.
Other factors increased equity by 1,623,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	AU$-1.72 Million	-17.18%
Share Repurchases	AU$564.00K	-5.63%
Share Issuances	AU$4.66 Million	+46.47%
Other Comprehensive Income	AU$-432.00K	-4.31%
Other Changes	AU$1.62 Million	+16.19%
Total Change	AU$-	55.15%

Book Value vs Market Value Analysis

This analysis compares Elixinol Wellness Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.11x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has increased from 0.00x to 0.11x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	AU$3.43	AU$0.01	x
2017-12-31	AU$0.65	AU$0.01	x
2018-12-31	AU$1.09	AU$0.01	x
2019-12-31	AU$0.57	AU$0.01	x
2020-12-31	AU$0.15	AU$0.01	x
2021-12-31	AU$0.05	AU$0.01	x
2022-12-31	AU$0.02	AU$0.01	x
2023-12-31	AU$0.01	AU$0.01	x
2024-12-31	AU$0.06	AU$0.01	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Elixinol Wellness Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -17.18%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -11.51%
• Asset Turnover: 0.81x
• Equity Multiplier: 1.84x
Recent ROE (-17.18%) is above the historical average (-50.64%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2002	28.25%	18.22%	0.60x	2.59x	AU$16.47 Million
2003	17.26%	13.88%	0.57x	2.17x	AU$10.80 Million
2004	26.91%	17.57%	0.59x	2.61x	AU$39.50 Million
2005	26.75%	18.93%	0.54x	2.63x	AU$61.41 Million
2017	-2.74%	-135550.00%	0.00x	1.06x	AU$-12.62 Million
2018	-0.60%	-2.32%	0.24x	1.07x	AU$-15.23 Million
2019	-72.36%	-262.50%	0.25x	1.09x	AU$-91.77 Million
2020	-293.14%	-696.24%	0.35x	1.19x	AU$-108.07 Million
2021	-89.24%	-182.32%	0.37x	1.33x	AU$-18.93 Million
2022	-115.43%	-149.84%	0.52x	1.47x	AU$-11.49 Million
2023	-116.17%	-90.78%	0.71x	1.81x	AU$-8.15 Million
2024	-17.18%	-11.51%	0.81x	1.84x	AU$-2.72 Million

Industry Comparison

This section compares Elixinol Wellness Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $30,995,633
Average return on equity (ROE) among peers: -1183.42%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Elixinol Wellness Ltd (EXL)	AU$6.96 Million	28.25%	1.38x	$2.05 Million
Althea Group Holdings Ltd (AGH)	$314.00K	-10209.24%	74.32x	$12.05 Million
BOD Science Ltd (BOD)	$2.07 Million	-368.90%	0.69x	$3.01 Million
BPH Global Ltd (BP8)	$12.64 Million	8.57%	1.99x	$2.62 Million
Cann Group Ltd (CAN)	$84.90 Million	-31.17%	0.64x	$5.62 Million
ECS Botanics Holdings Ltd (ECS)	$22.20 Million	-0.37%	0.18x	$5.65 Million
Ecofibre Ltd (EOF)	$109.94 Million	-13.34%	0.36x	$5.36 Million
Epsilon Healthcare Ltd (EPN)	$21.36 Million	-11.98%	0.03x	$5.51 Million
IDT Australia Ltd (IDT)	$25.01 Million	-24.32%	0.25x	$12.10 Million
Invion Ltd (IVX)	$529.00K	0.00%	2.90x	$3.76 Million

About Elixinol Wellness Ltd

AU:EXL Australia Drug Manufacturers - Specialty & Generic

Market Cap

$2.05 Million

AU$2.90 Million AUD

Market Cap Rank

#29661 Global

#1759 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$4.91